These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37694076)

  • 21. Salivary MMP-9 as a Biomarker for the Diagnosis of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
    Smriti K; Ray M; Chatterjee T; Shenoy RP; Gadicherla S; Pentapati KC; Rustaqi N
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):233-238. PubMed ID: 31983189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and factors associated with oral potentially malignant disorders and oral squamous cell carcinoma: An institutional study.
    Shah JS; Dubey J
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S536-S544. PubMed ID: 38384016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of salivary lactate dehydrogenase isoenzyme levels in patients with oral leukoplakia and squamous cell carcinoma by gel electrophoresis method.
    Joshi PS; Golgire S
    J Oral Maxillofac Pathol; 2014 Sep; 18(Suppl 1):S39-44. PubMed ID: 25364177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Salivary and Serum Alkaline Phosphates Level and Lactate Dehydrogenase Levels in Patients with Tobacco Related Oral Lesions with Healthy Subjects - A Step Towards Early Diagnosis.
    Goyal G
    Asian Pac J Cancer Prev; 2020 Apr; 21(4):983-991. PubMed ID: 32334459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimation of Salivary 8-Hydroxydeoxyguanosine (8-OHdG) as a Potential Biomarker in Assessing Progression towards Malignancy: A Case-Control Study.
    Nandakumar A; Nataraj P; James A; Krishnan R; K M M
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2325-2329. PubMed ID: 32856861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salivary L-fucose as a biomarker for oral potentially malignant disorders and oral cancer.
    Sharma M; Sharma E; Prabhu V; Pai VR; D'souza JM; Harish S; Jose M
    J Cancer Res Ther; 2020; 16(3):546-550. PubMed ID: 32719265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Serum and Salivary Lactate Dehydrogenase Levels in Patients with Oral Potentially Malignant Conditions/Lesions: A Clinical and Biochemical Study.
    Rao K; Babu SG; Shetty SR; Castelino RL
    Indian J Community Med; 2024; 49(2):316-321. PubMed ID: 38665466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimation of salivary lactate dehydrogenase in oral leukoplakia and oral squamous cell carcinoma: a biochemical study.
    Patel S; Metgud R
    J Cancer Res Ther; 2015; 11(1):119-23. PubMed ID: 25879348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum lactate dehydrogenase in the prognostic assessment of patients with oral squamous cell carcinoma.
    Sudha J; Julius A; Jimson S; Padmavathy K
    Indian J Dent Res; 2022; 33(2):164-168. PubMed ID: 36254953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salivary lactate dehydrogenase as a prognostic marker in oral squamous cell carcinoma patients following surgical therapy.
    Pathiyil V; D'Cruz AM
    J Exp Ther Oncol; 2017 Sep; 11(2):133-137. PubMed ID: 28976136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Could salivary biomarkers be useful in the early detection of oral cancer and oral potentially malignant disorders, and is there a relationship between these biomarkers and risk factors?
    Elmahgoub F
    Evid Based Dent; 2022 Mar; 23(1):30-31. PubMed ID: 35338326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of S100 A7 as a diagnostic biomarker in oral potentially malignant disorders and oral cancer.
    Sood A; Mishra D; Kharbanda OP; Chauhan SS; Gupta SD; Deo SSV; Yadav R; Ralhan R; Kumawat R; Kaur H
    J Oral Maxillofac Pathol; 2022; 26(2):166-172. PubMed ID: 35968185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-invasive screening of a microRNA-based dysregulation signature in oral cancer and oral potentially malignant disorders.
    Yap T; Seers C; Koo K; Cheng L; Vella LJ; Hill AF; Reynolds E; Nastri A; Cirillo N; McCullough M
    Oral Oncol; 2019 Sep; 96():113-120. PubMed ID: 31422202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Verification of Saliva Matrix Metalloproteinase-1 as a Strong Diagnostic Marker of Oral Cavity Cancer.
    Chang YT; Chu LJ; Liu YC; Chen CJ; Wu SF; Chen CH; Chang IY; Wang JS; Wu TY; Dash S; Chiang WF; Chiu SF; Gou SB; Chien CY; Chang KP; Yu JS
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32823758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of vitamin D levels in patients with oral potentially malignant disorders and oral squamous cell carcinoma-A cross-sectional study.
    Samanta I; Patil DJ; More CB
    J Oral Biol Craniofac Res; 2024; 14(1):27-32. PubMed ID: 38130424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Value of Cancer Stem Cell Markers in Potentially Malignant Disorders of Oral Mucosa: A Meta-analysis.
    Saluja TS; Ali M; Mishra P; Kumar V; Singh SK
    Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):144-153. PubMed ID: 30315141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystallization test: A prognostic biomarker in oral potentially malignant disorders and oral cancer.
    Joshi K; Shah J
    Indian J Pathol Microbiol; 2024 Jun; ():. PubMed ID: 38847217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum C-reactive protein in oral submucous fibrosis and oral squamous cell carcinoma: A cross-sectional study.
    Gosavi SR; Torkadi AA
    J Oral Maxillofac Pathol; 2020; 24(1):46-51. PubMed ID: 32508447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of matrix metalloproteinase-9 in oral potentially malignant disorders: A systematic review.
    Venugopal A; Uma Maheswari TN
    J Oral Maxillofac Pathol; 2016; 20(3):474-479. PubMed ID: 27721614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salivary Lactate Dehydrogenase as a Potential Biomarker in Oral Potentially Malignant Disorders and Head & Neck Cancer- A Systematic Review and Meta-analysis.
    S LK; Naik Z; Lagali-Jirge V; M S; Panwar A; Keluskar V
    Gulf J Oncolog; 2023 Jan; 1(41):78-99. PubMed ID: 36804163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.